Coverage dated December 8, 2021 to December 9, 2021
U.S. expands Pfizer COVID boosters 16-year-olds
Headline from The Columbian
U.S. health authorities again expanded the nation’s booster campaign Thursday, opening extra doses of Pfizer’s COVID-19 vaccine to several million 16- and 17-year-olds.
The Columbian's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
By Jamie Gumbrecht, CNN The US Food and Drug Administration on Thursday authorized the Pfizer/BioNTech Covid-19 vaccine for use as a booster in people ages 16 and 17. It’s the first Covid-19 vaccine booster authorized for this age group in the United States.
The Food and Drug Administration has given emergency authorization for 16- and 17-year-olds to get a third dose of the vaccine made by Pfizer and its partner BioNTech -- if it's been six months since their last shot.
The Food and Drug Administration on Thursday authorized a booster shot of the Pfizer-BioNTech Covid-19 vaccine for teens ages 16 and 17 for emergency use.
The Food and Drug Administration (FDA) on Thursday authorized booster shots of Pfizer and BioNTech's coronavirus vaccine for 16 and 17 year olds, a move meant to bolster protection against the delta and emerging omicron variant.
The Food and Drug Administration authorized Pfizer booster shots for 16- and 17-year-olds on Thursday, clearing a hurdle for about 2.6 million more people to get a second dose of the COVID-19 vaccine.
By Jamie Gumbrecht, CNN The US Food and Drug Administration on Thursday authorized the Pfizer/BioNTech Covid-19 vaccine for use as a booster in people ages 16 and 17, and the US Centers for Disease Control and Prevention recommended it for this age group.
There's one more step: The Centers for Disease Control and Prevention must formally recommend the boosters for this age group and a decision is expected soon.
The Centers for Disease Control and Prevention on Thursday signed off on booster shots of Pfizer and BioNTech's coronavirus vaccine for 16 and 17-year-olds who are six months past their second shot, clearing the way
The US Food and Drug Administration (FDA) on Thursday expanded authorization of the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds, amid growing concern over the Omicron variant's abil…
U.S. health authorities said Thursday that 16- and 17-year-olds should get a booster dose of Pfizer’s covid-19 vaccine once they’re six months past their last shot. The U.S. and many other nations already were urging adults to get booster shots to pump up immunity that can wane months after vaccinat…
Showing the first 25 of 33 headlines. ·
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
